![]() |
市場調査レポート
商品コード
1756003
自動細胞振とう器の世界市場:製品タイプ別、周波数帯域別、用途別、エンドユーザー別、地域別、機会、予測、2018年~2032年Automated Cell Shakers Market Assessment, By Product Type, By Frequency Band, By Application, By End-user, By Region, Opportunities and Forecast, 2018-2032F |
||||||
カスタマイズ可能
|
自動細胞振とう器の世界市場:製品タイプ別、周波数帯域別、用途別、エンドユーザー別、地域別、機会、予測、2018年~2032年 |
出版日: 2025年06月25日
発行: Markets & Data
ページ情報: 英文 245 Pages
納期: 3~5営業日
|
世界の自動細胞振とう器の市場規模は、予測期間の2025年~2032年に6.34%のCAGRで拡大し、2024年の7億112万米ドルから2032年には11億4,811万米ドルに成長すると予測されています。高度なラボラトリーオートメーションシステムに対する需要の高まりが、自動細胞振とう器の採用を大きく後押ししています。
バイオテクノロジーと製薬の研究室は、研究センターとともに、自動細胞振とう器の一貫した市場拡大を牽引しています。これらの装置は、成長環境を最適化するために制御された加振を提供することにより、細胞培養操作中に不可欠な機器として機能します。自動加振器は、自動化によって手動モデルよりも優れた性能を発揮し、オペレーターのミスを最小限に抑え、広範な製造作業をサポートします。市場開拓の原動力となるのは、細胞ベースの研究開発とバイオ医薬品への資金提供の増加、そして一貫した成果への要求という3つの要素です。
この装置は、プログラム可能な制御とリアルタイムの追跡によってスマートな機能を実現し、ラボ情報システムとの統合を可能にします。北米と欧州は研究インフラが発達しているため、市場は最高レベルに達しているが、アジア太平洋はバイオ産業の拡大により市場成長を牽引しています。市場リーダーは、エネルギー効率の高い設計と容器の互換性を備えたモジュール式の要素を組み合わせた新製品のリリースにリソースを投入しています。自動細胞振とう器市場は、技術の進歩と医薬品開発や合成生物学における用途の拡大により成長を続けています。さらに、各社は自動細胞振とう器市場をサポートするために協力しています。
例えば、2023年5月、Cytiva Bioscience Holding Ltd.はPall Corporation Life Scienceとの提携を発表し、世界のバイオテクノロジーイノベーションリーダーを設立しました。この合併により、同社のバイオプロセス能力は拡大し、生物製剤やワクチン開発をサポートする能力が高まっています。この戦略的決定により、バイオテクノロジー業界における同社の市場地位が向上し、イノベーションのスピードと経営効率の両方が促進されました。
当レポートでは、世界の自動細胞振とう器市場について調査し、市場の概要とともに、製品タイプ別、周波数帯域別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。
Global automated cell shakers market is projected to witness a CAGR of 6.34% during the forecast period 2025-2032, growing from USD 701.12 million in 2024 to USD 1148.11 million in 2032. The increasing demand for advanced laboratory automation systems is significantly boosting the adoption of automated cell shakers.
Biotechnology and pharmaceutical research laboratories, together with research centers, drive consistent market expansion for automated cell shaker equipment. These devices serve as essential instruments during cell culture operations by delivering controlled shaking to optimize growth environments. Automated shakers deliver superior performance compared to manual models through automation, which minimizes operator mistakes and supports extensive manufacturing operations. Three main factors drive market expansion: developments in cell-based research and rising biopharmaceutical funding and the requirement for consistent outcomes.
The devices enable smart functions through programmable controls and real-time tracking coupled with laboratory information system integration. The market reaches its highest level in North America and Europe because of their advanced research infrastructure, yet Asia-Pacific leads to market growth with its expanding biotech industry. The market leaders invest their resources into releasing new products that combine modular elements with energy-efficient designs and vessel compatibility. The automated cell shaker market continues to grow because of technological advancements and expanding applications in drug development and synthetic biology. Additionally, the companies are collaborating to support the automated cell shakers market.
For instance, in May 2023, Cytiva Bioscience Holding Ltd. announced a collaboration with Pall Corporation Life Science to establish a worldwide biotechnology innovation leader. The merger expanded their bioprocessing abilities, which boosted their ability to support biologics and vaccine development. The strategic decision enhanced their market standing within biotechnology, which drove both innovation speed and operational effectiveness.
Rising Demand for Cell-Based Research Boosts Market Demand
The rising demand for cell-based research in drug development, biotechnology, and regenerative medicine is significantly boosting the market shares of automated cell shakers. Cell culture applications depend on these devices to maintain uniform agitation and optimal nutrient flow, which enhances cell survival necessary for drug discovery, vaccine creation, and regenerative medicine procedures. High-throughput screening and precision-based studies within research facilities require automated cell shakers, as these devices deliver enhanced efficiency and reproducible results while minimizing contamination compared to the manual method. Programmable controls, compact designs, and lab automation integration systems drive higher adoption rates. The automated cell shaker market is expected to sustain its growth through rising R&D investments and the expansion of biological production, capturing a larger share of the life sciences equipment sector.
Additionally, the research study and clinical trials can also boost the demand for the automated cell shakers market. For instance, in March 2024, the Society for Laboratory Automation and Screening (SLAS) researched Skin Cutaneous Melanoma Prognosis, Nanoliter Droplet Handling for Enhanced Laboratory Efficiency, and other areas of life science technology. This research activity increased the demand for cell shakers.
Increasing Adoption of Laboratory Automation Drives Market Expansion
The rapid expansion of laboratory automation drives the growth of the automated cell shaker market at a fast pace. Global laboratories that strive for enhanced efficiency, accuracy, and reproducibility require automated solutions as essential tools. Automated shakers used in cell culture workflows remove operator dependence, so they minimize human mistakes while maintaining consistent shaking conditions. The need to perform high-throughput screening in drug discovery, as well as biotechnology and academic research, drives substantial market expansion. Automated systems enable laboratories to enhance process efficiency while reducing costs and boosting their productivity levels. Automated cell shakers gain market preference because technological progress enables programmable speed functions with temperature control and remote monitoring features. The market experiences fast expansion because biopharmaceutical research expands, and organizations need scalable solutions. The automated cell shaker market experiences rapid growth because laboratories pursue precision and efficiency, while new technologies emerge and laboratory automation expands across the industry. For instance, in September 2023, Kuhner Shaker launched new white versions of its LT-X(C) and ISF4-X(C) incubator shaker models, catering to aesthetic preferences and expanding their product portfolio to appeal to a broader user base. The new launches have driven laboratories to adopt automatic cell shakers because diagnostic centers now use advanced technology for enhanced quality.
Pharmaceutical Companies and Biopharmaceutical Companies Hold Largest Market Shares
Pharmaceutical and biopharmaceutical companies hold the largest market shares of the automated cell shakers market. The precise and scalable nature of automated cell shakers meet the pharmaceutical industry's rising demand for efficient cell culture processes during drug development and bioprocessing. Through automated cell shakers, companies boost their productivity levels because these devices deliver steady agitation and optimal growth conditions while minimizing contamination risks. These sectors allocate substantial capital toward purchasing modern laboratory equipment to optimize their research and production activities, to lead market expansion. The implementation of strict regulatory requirements creates an increased need for dependable automatic systems, which drives market growth. The growing biopharmaceutical market, especially those focused on biologics and cell-based treatments, strengthens this ongoing development. Pharmaceutical and biopharmaceutical companies maintain their market dominance through rapid innovation, which drives their continued adoption of automated cell shakers.
For instance, in October 2024, Eppendorf introduced the CellXpert CS220, the first CO2 incubator shaker with a built-in 180 degrees Celsius sterilisation cycle. Tailored for mammalian cell cultivation, enhanced contamination prevention, accommodated more flasks, and included a streamlined chamber for simplified cleaning. The device also showcased a compact design, delivering the highest platform-to-footprint ratio.
North America Dominates the Global Automated Cell Shakers Market Size
North America dominates the automated cell shakers market, holding the largest share due to advanced healthcare systems, the presence of major industry players, and strong research funding. The rising popularity of biopharmaceuticals, cell culture technologies, and laboratory automation drives the region's expansion. The United States leads the market due to its superior research capabilities combined with broad technological implementation and large life science capital. The growing market receives extra support for its increasing focus on drug development and regenerative medicine applications. The Canadian government supports its biotech industry through its official programs that promote development activities. Research facilities, clinical settings, and industrial labs are increasing their use of automated cell shakers to emphasize a precision medicine approach and personalized therapy development. Research organizations, together with pharmaceutical companies, create partnerships to advance technological development in North America. The regulatory systems across North America favor innovative approaches as they maintain quality standards to protect the market's leadership standing.
Furthermore, to support market expansion in this region, key players in this region are launching new products. For instance, in March 2025, Caron Scientific Inc. launched the 7406 Incubator Shaker at the EU Advanced Therapies conference. The unit featured the highest capacity in a compact footprint, H2O2 fogging sterilization, and a dry humidity control system without standing water. It offered faster turnaround, minimized contamination risks, and efficiently met GMP compliance needs.
Impact of U.S. Tariffs on the Global Automated Cell Shakers Market
The U.S. tariffs on imported merchandise specifically affect the automated cell shakers market through their impact on Chinese products. The essential biotechnology and pharmaceutical research equipment, known as automated cell shakers, needs global supply chains to achieve cost-effective production. The implementation of tariffs has driven up costs for United States buyers, decreasing the affordability of equipment for laboratory facilities and research establishments. The rising costs of imported components create pressure on the profit margins of domestic manufacturers. Businesses that need to switch to non-tariff countries for sourcing will experience supply chain disruptions because it requires both time and financial investment. Small businesses face the most significant impact from tariffs because they cannot negotiate effectively, which limits their ability to innovate. Tariffs increase the appeal of domestic production, yet the United States does not possess sufficient manufacturing capacity to fulfill market requirements. The tariffs create budget constraints while slowing research progress and generating market instability, which results in reduced market development. The current protectionist approach creates a challenging situation that may slow down the vital biotechnology sector.
Key Players Landscape and Outlook
Companies are expanding their market footprint via product development and automated system implementation, along with improved user-centered design approaches. Companies pursue their growth objectives by creating models that handle large volumes efficiently while conserving energy and by making their products compatible with laboratory automation systems. The industry shows positive prospects because AI-based optimization systems, together with remote monitoring capabilities and modular design approaches, are defining future market directions. The increasing market rivalry drives producers to develop precise, scalable products at affordable prices that match multiple laboratory requirements.
In June 2024, Thermo Fisher Scientific Inc. launched the fully integrated IntelliStack Incubator and CO2 Incubator Shakers for precise and reproducible cell culture control. The stackable units featured a 10-inch touchscreen, 5L capacity, and flexible configurations with CO2 and non-CO2 shakers. The solution targets biotech, biopharma, and academic sectors, supports automated cell therapy production, and addresses contamination risks.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.